Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_519d19dae650 in signals
id
sig_519d19dae650
Primary key.
TEXT
event_id
7299
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","company":"Roivant Sciences Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","article_chars":1666,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_07c5aebfc7fdb2ee","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","content_type":"text/plain","enriched_at":"2026-04-09T19:30:51.023995+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt","source_event_id":"evt_86a6d89e5134","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"ac75d1882efdcd42","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-08","2026-03-20","2026-04-09"],"entities":[{"asset_class":"equity","name":"Roivant Sciences Ltd.","relevance":"high","symbol":"ROIV","type":"issuer"},{"asset_class":"person","name":"Jennifer Humes","relevance":"high","symbol":"","type":"reporting_owner_signatory"},{"asset_class":"broker_dealer","name":"Morgan Stanley Smith Barney LLC","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The provided text does not clearly specify the exact Form 144 purpose details (e.g., whether it is a sale, transfer, or other disposition) beyond the presence of restricted stock-related fields.","The text includes numeric fields (e.g., 13538, 384035.15, 715701137) but does not label them in a way that allows unambiguous mapping to shares vs. proceeds vs. other metrics.","No prior known state is included in the prompt, so the 'delta vs prior' change cannot be determined from the provided content alone."],"key_facts":["SEC filing type: Form 144.","Issuer/subject company: Roivant Sciences Ltd. (CIK 0001635088).","Filed as of date: 2026-04-08; accession number: 0001950047-26-003307.","Reporting owner: Jennifer Humes (CIK 0002058012), identified as an officer (Common).","Restricted stock issuer: indicated as 'Restricted Stock Issuer N'.","Transaction date shown: 03/20/2026 (also appears as '04/08/2026' in the filing values).","Broker/financial services entity listed: Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.","Signature: /s/ Jennifer Humes, dated 04/08/2026."],"numeric_claims":[{"label":"Filing accession number","value":"0001950047-26-003307"},{"label":"Filed as of date","value":"2026-04-08"},{"label":"Transaction date shown","value":"2026-03-20"},{"label":"Number of shares/units (as shown in text)","value":"13538"},{"label":"Price/amount (as shown in text)","value":"384035.15"},{"label":"Another numeric field (as shown in text)","value":"715701137"}],"primary_claim":"Roivant Sciences Ltd. submitted SEC Form 144 filed as of 2026-04-08 (accession 0001950047-26-003307).","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Roivant Sciences Ltd. filed a Form 144 on 2026-04-08. The filing relates to restricted stock with a transaction date of 2026-03-20 and includes an officer signatory (Jennifer Humes).","topics":["SEC Form 144","restricted stock","insider/officer sale notice","Roivant Sciences Ltd."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Roivant Sciences Ltd. \u00b7 Filed 20260408","ticker":"ROIV","tickers":["ROIV"],"title":"ROIV filed 144","url":"https://www.sec.gov/Archives/edgar/data/1635088/0001950047-26-003307.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_86a6d89e5134"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:78e5096aeeaa4f9c
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-09T03:12:49.786272+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel